{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"type-a-insulin-resistance","columns":[{"gene":"","key":"population-4475d816567b059e0d47","label":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","mondoId":"MONDO:0012520","onsetQualifier":null,"originColumnKey":"MONDO:0012520/OMIM:610549","originalViews":[{"key":"MONDO:0012520/OMIM:610549","label":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","scopeLabel":"OMIM:610549","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0eb39d038e7304a9e72d5f9e7988955acf2a689ec4dbc3aa0f6bd256ad8d6320","1f4659a8dd7783922885393eee51be5546c09ea57cf726edc6274e7a84613cbe","33898f4ecacd5a4e23cf9760aaa3c026020e2752bb9d38d6197fc4cfae8c2f6e","3bb676811ff54b47538b0da930760b131955ddbab52c9a99507aa24d7d466ea4","5184bd3e509bed1582bbe99c249f30345d1ec69af444f1ff56cc77996d617c83","5ea321711162c605312cde700a1f6ddcc8b05d436ed82085dec09726cb237738","73ae6f83e0a00790b6e3a8612be420e1c7cdf54fbf6638646331d401db6ef3bc","97a8c9af6608ec227375f212f15b78e54c2ff8498a4dd8c26ff8637e223668e4","9e5dab82b6168dc1927b1ddab4a5c3a1831e4936224aec946aea0698cad23598","e68e226961af04081fc57e618cbd943367adc5ec19474630d85927342ece52af","eef60d67d78833ee372db2921df740b8b99fea9018d1b19a191a394f3e91c693"],"recordQualifiers":{},"scopeLabel":"OMIM:610549","sourceIds":["OMIM:610549"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-4679d32520be3e6c0f49","label":"Insulin-resistance syndrome type A","mondoId":"MONDO:0012520","onsetQualifier":null,"originColumnKey":"MONDO:0012520/ORPHA:2297","originalViews":[{"key":"MONDO:0012520/ORPHA:2297","label":"Insulin-resistance syndrome type A","scopeLabel":"ORPHA:2297","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["029bf542b7c5b4959eb1ba75e296ffa2573b7c9a9214d5e7e599ea4de3527b65","3bfcd4463d087634f4705b8397b9551ca1fbf03d2d2c6eef5268902e925a2b2b","a35f7aad823a8c68c556943f0d47290ba9a5ae858a8c81780c0469737d72d155","c9fff97f43f6a35713b115e048e0ff6581a1d67b3eee63e65da2d2578828ea64","cd41bc8bce4bf8d3cb7176ae21ec791863565a14afb1eb0be0872fc7756835eb","eb362f28aea724ab5658deba25ee4d05c8a2f4a38072de2c7fd85f341640e416","f8a6bd3a97db1d679581a58811d26f2744d7828a4362725465d4c5b55bc7bd8d"],"recordQualifiers":{},"scopeLabel":"ORPHA:2297","sourceIds":["ORPHA:2297"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-4475d816567b059e0d47","population-4679d32520be3e6c0f49"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000956","HP:0005616","HP:0000141","HP:0000823","HP:0025092","HP:0008283","HP:0002230"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":11,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":18,"sourceGroups":{"orphanet":7,"published":11}},"features":[{"hpoId":"HP:0000956","label":"Acanthosis nigricans","primary":true},{"hpoId":"HP:0005616","label":"Accelerated skeletal maturation","primary":true},{"hpoId":"HP:0000141","label":"Amenorrhea","primary":true},{"hpoId":"HP:0000823","label":"Delayed puberty","primary":true},{"hpoId":"HP:0025092","label":"Epidermal acanthosis","primary":true},{"hpoId":"HP:0008283","label":"Fasting hyperinsulinemia","primary":true},{"hpoId":"HP:0002230","label":"Generalized hirsutism","primary":true},{"hpoId":"HP:0007440","label":"Generalized hyperpigmentation","primary":false},{"hpoId":"HP:0001007","label":"Hirsutism","primary":false},{"hpoId":"HP:0000962","label":"Hyperkeratosis","primary":false},{"hpoId":"HP:0025691","label":"Impaired fasting glucose","primary":false},{"hpoId":"HP:0040270","label":"Impaired glucose tolerance","primary":false},{"hpoId":"HP:0030348","label":"Increased circulating androgen concentration","primary":false},{"hpoId":"HP:0000855","label":"Insulin resistance","primary":false},{"hpoId":"HP:0000831","label":"Insulin-resistant diabetes mellitus","primary":false},{"hpoId":"HP:0000147","label":"Polycystic ovaries","primary":false},{"hpoId":"HP:0001482","label":"Subcutaneous nodule","primary":false},{"hpoId":"HP:0005978","label":"Type II diabetes mellitus","primary":false}],"ledeHtml":"Type A insulin-resistance syndrome belongs to the group of extreme insulin-resistance syndromes (which includes leprechaunism, the lipodystrophies, Rabson-Mendenhall syndrome and type B insulin resistance syndrome) and is characterized by the triad of hyperinsulinemia, acanthosis nigricans (skin lesions associated with insulin resistance), and signs of hyperandrogenism in females without lipodystrophy and who are not overweight.","mondoId":"MONDO:0012520","node":{"canonicalSlug":"type-a-insulin-resistance","comparisons":[{"documentSha256":"b26ca972cecc7a41a1b9896dcd88f94c26258c20bc62c5df0cc67f8705d6c89e","key":"legacy-type-a-insulin-resistance","kind":"legacy","label":"insulin-resistance syndrome type A","memberIds":["MONDO:0012520"],"mondoId":"MONDO:0012520","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/type-a-insulin-resistance.b26ca972cecc7a41a1b9896dcd88f94c26258c20bc62c5df0cc67f8705d6c89e.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"insulin-resistance syndrome type A","paragraphs":["Type A insulin-resistance syndrome belongs to the group of extreme insulin-resistance syndromes (which includes leprechaunism, the lipodystrophies, Rabson-Mendenhall syndrome and type B insulin resistance syndrome) and is characterized by the triad of hyperinsulinemia, acanthosis nigricans (skin lesions associated with insulin resistance), and signs of hyperandrogenism in females without lipodystrophy and who are not overweight."],"scope":"exact","source":"MONDO","upstream":"Orphanet:2297","url":"https://monarchinitiative.org/MONDO:0012520"},"ownColumnKeys":["population-4475d816567b059e0d47","population-4679d32520be3e6c0f49"],"publication":"published","relationships":[{"kind":"parent","label":"endocrine pancreas disorder","mondoId":"MONDO:0001933","slug":null},{"kind":"parent","label":"hereditary disease","mondoId":"MONDO:0003847","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"synonym-scope-not-retained","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/type-a-insulin-resistance-syndrome"},{"reason":"Name scope not exact or reviewed","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/3008"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"029bf542b7c5b4959eb1ba75e296ffa2573b7c9a9214d5e7e599ea4de3527b65","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2297","disease_name":"Insulin-resistance syndrome type A","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007440","is_excluded":false,"label":"Generalized hyperpigmentation","onset_id":null,"reference":"ORPHA:2297","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"0eb39d038e7304a9e72d5f9e7988955acf2a689ec4dbc3aa0f6bd256ad8d6320","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000855","is_excluded":false,"label":"Insulin resistance","onset_id":null,"reference":"PMID:8288049","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1f4659a8dd7783922885393eee51be5546c09ea57cf726edc6274e7a84613cbe","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0040270","is_excluded":false,"label":"Impaired glucose tolerance","onset_id":null,"reference":"PMID:8288049;PMID:2544998","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"33898f4ecacd5a4e23cf9760aaa3c026020e2752bb9d38d6197fc4cfae8c2f6e","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0000956","is_excluded":false,"label":"Acanthosis nigricans","onset_id":null,"reference":"PMID:8288049;PMID:2544998","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3bb676811ff54b47538b0da930760b131955ddbab52c9a99507aa24d7d466ea4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"0/1","hpo_id":"HP:0025691","is_excluded":true,"label":"Impaired fasting glucose","onset_id":null,"reference":"PMID:2544998","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"3bfcd4463d087634f4705b8397b9551ca1fbf03d2d2c6eef5268902e925a2b2b","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2297","disease_name":"Insulin-resistance syndrome type A","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000962","is_excluded":false,"label":"Hyperkeratosis","onset_id":null,"reference":"ORPHA:2297","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"5184bd3e509bed1582bbe99c249f30345d1ec69af444f1ff56cc77996d617c83","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000831","is_excluded":false,"label":"Insulin-resistant diabetes mellitus","onset_id":null,"reference":"PMID:2544998","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"5ea321711162c605312cde700a1f6ddcc8b05d436ed82085dec09726cb237738","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0025092","is_excluded":false,"label":"Epidermal acanthosis","onset_id":null,"reference":"PMID:8288049","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"73ae6f83e0a00790b6e3a8612be420e1c7cdf54fbf6638646331d401db6ef3bc","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000147","is_excluded":false,"label":"Polycystic ovaries","onset_id":null,"reference":"PMID:8288049","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"97a8c9af6608ec227375f212f15b78e54c2ff8498a4dd8c26ff8637e223668e4","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000141","is_excluded":false,"label":"Amenorrhea","onset_id":null,"reference":"PMID:8288049","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9e5dab82b6168dc1927b1ddab4a5c3a1831e4936224aec946aea0698cad23598","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001007","is_excluded":false,"label":"Hirsutism","onset_id":null,"reference":"PMID:8288049","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"a35f7aad823a8c68c556943f0d47290ba9a5ae858a8c81780c0469737d72d155","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:2297","disease_name":"Insulin-resistance syndrome type A","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000823","is_excluded":false,"label":"Delayed puberty","onset_id":null,"reference":"ORPHA:2297","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c9fff97f43f6a35713b115e048e0ff6581a1d67b3eee63e65da2d2578828ea64","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2297","disease_name":"Insulin-resistance syndrome type A","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0005616","is_excluded":false,"label":"Accelerated skeletal maturation","onset_id":null,"reference":"ORPHA:2297","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cd41bc8bce4bf8d3cb7176ae21ec791863565a14afb1eb0be0872fc7756835eb","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2297","disease_name":"Insulin-resistance syndrome type A","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001482","is_excluded":false,"label":"Subcutaneous nodule","onset_id":null,"reference":"ORPHA:2297","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"e68e226961af04081fc57e618cbd943367adc5ec19474630d85927342ece52af","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0030348","is_excluded":false,"label":"Increased circulating androgen concentration","onset_id":null,"reference":"PMID:8288049","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"eb362f28aea724ab5658deba25ee4d05c8a2f4a38072de2c7fd85f341640e416","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:2297","disease_name":"Insulin-resistance syndrome type A","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0005978","is_excluded":false,"label":"Type II diabetes mellitus","onset_id":null,"reference":"ORPHA:2297","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"eef60d67d78833ee372db2921df740b8b99fea9018d1b19a191a394f3e91c693","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0008283","is_excluded":false,"label":"Fasting hyperinsulinemia","onset_id":null,"reference":"PMID:8288049;PMID:2544998","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"f8a6bd3a97db1d679581a58811d26f2744d7828a4362725465d4c5b55bc7bd8d","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2297","disease_name":"Insulin-resistance syndrome type A","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002230","is_excluded":false,"label":"Generalized hirsutism","onset_id":null,"reference":"ORPHA:2297","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012520\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:2297</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Type A insulin-resistance syndrome belongs to the group of extreme insulin-resistance syndromes (which includes leprechaunism, the lipodystrophies, Rabson-Mendenhall syndrome and type B insulin resistance syndrome) and is characterized by the triad of hyperinsulinemia, acanthosis nigricans (skin lesions associated with insulin resistance), and signs of hyperandrogenism in females without lipodystrophy and who are not overweight.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012520\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"type-a-insulin-resistance","sourceDocuments":[{"name":"MONDO: insulin-resistance syndrome type A","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0012520"}],"sourceNote":"","synonyms":["insulin resistant diabetes mellitus with acanthosis nigricans and hyperandrogenism","insulin-resistant acanthosis nigricans, type A","type A insulin resistance syndrome"],"takeawayHtml":"","title":"insulin-resistance syndrome type A"},"schemaVersion":1}
